SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
SKINVISIBLE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.16+0.00 (+0.06%)
Close on Oct 19, 2026
- Market cap
- $843.54K
- P/E (TTM)
- –
- Dividend yield
- –
Skinvisible statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Skinvisible | Industry median |
|---|---|---|
| Market Cap | $843.54K | $166.30M |
| Enterprise Value | $839.58K | $88.19M |
| PS Ratio | 42.18 | 3.65 |
| P/OCF Ratio | 219.79 | 12.98 |
Enterprise value
| Measure | Skinvisible | Industry median |
|---|---|---|
| EV / Sales | 41.98 | 2.51 |
Income (trailing twelve months)
| Measure | Skinvisible | Industry median |
|---|---|---|
| Revenue | $20.00K | $58.34M |
| Gross Profit | $20.00K | $105.94M |
| Operating Income | -$458.98K | -$21.40M |
| Net Income | -$1.03M | -$22.46M |
| EBITDA | -$438.74K | -$16.91M |
| EPS (Diluted) | -$0.20 | -$0.83 |
Margins
| Measure | Skinvisible | Industry median |
|---|---|---|
| Gross Margin | 100.0% | 52.9% |
| Operating Margin | -2294.9% | -44.0% |
| Profit Margin | -5156.6% | -40.2% |
| EBITDA Margin | -2193.7% | -30.2% |
Returns
| Measure | Skinvisible | Industry median |
|---|---|---|
| Return on Assets (ROA) | -773.4% | -40.9% |
Growth
| Measure | Skinvisible | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 0.00% | 5.96% |
| Revenue Growth (3Y CAGR) | -58.5% | 2.25% |
| Revenue Growth (5Y CAGR) | -33.4% | 6.48% |
Balance sheet
| Measure | Skinvisible | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.96K | $61.43M |
| Net Cash (Debt) | $3.96K | $15.35M |
| Net Cash Per Share | $0.00 | $0.66 |
| Equity (Book Value) | -$10.79M | $49.09M |
| Book Value Per Share | -$2.00 | $1.37 |
| Tangible Book Value | -$10.88M | $23.52M |
| Working Capital | -$5.50M | $76.81M |
Financial position
| Measure | Skinvisible | Industry median |
|---|---|---|
| Current Ratio | 0.01 | 3.34 |
| Quick Ratio | 0.00 | 2.44 |
| Interest Coverage | -0.80 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Skinvisible | Industry median |
|---|---|---|
| Operating Cash Flow | $3.84K | -$12.35M |
Efficiency
| Measure | Skinvisible | Industry median |
|---|---|---|
| Asset Turnover | 0.15 | 0.39 |
| Revenue Per Employee | $10.00K | $404.87K |
| Profits Per Employee | -$515.66K | -$703.34K |
| Employee Count | 2 | 74 |
Dividends and yields
| Measure | Skinvisible | Industry median |
|---|---|---|
| Earnings Yield | -122.3% | -23.3% |
Shares
| Measure | Skinvisible | Industry median |
|---|---|---|
| Shares Outstanding | 5,403,840 | 58,127,000 |
| Shares Change (YoY) | -1.44% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 5,403,840 | 49,136,700 |
| Shares Held by Insiders | 0.00% | 11.6% |
Scores
| Measure | Skinvisible | Industry median |
|---|---|---|
| Altman Z-Score | -537.07 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Skinvisible's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.